Understanding the Patterns of Serological Testing for COVID-19 Pre- and Post-Vaccination Rollout in Michigan.

J Clin Med · 2021 · PMC8509702 · PMID 34640359

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Seropositivity in the pre-vaccine launch period was 9.2% and increased to 36.2% (after removing tests after vaccination) in the post-vaccine launch period, an increasing trend that was observable in adults (9.1 to 37.1%) but also noted to some extent in adolescents (13.0 to 29.4%) and children (8.6 to 26.2%).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.